HEADER HYDROLASE 06-FEB-12 4AHI TITLE K40I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A TITLE 2 BIOCHEMICAL AND BIOLOGICAL ANALYSIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOGENIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RIBONUCLEASE 5, RNASE 5; COMPND 5 EC: 3.1.27.-; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: CODON PLUS - RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B(PLUS) KEYWDS HYDROLASE, AMYOTROPHIC, LATERAL SCLEROSIS, NEOVASCULARISATION EXPDTA X-RAY DIFFRACTION AUTHOR N.THIYAGARAJAN,R.FERGUSON,S.SAHA,T.PHAM,V.SUBRAMANIAN,K.R.ACHARYA REVDAT 3 20-DEC-23 4AHI 1 REMARK REVDAT 2 24-OCT-12 4AHI 1 JRNL REVDAT 1 10-OCT-12 4AHI 0 JRNL AUTH N.THIYAGARAJAN,R.FERGUSON,V.SUBRAMANIAN,K.R.ACHARYA JRNL TITL STRUCTURAL AND MOLECULAR INSIGHTS INTO THE MECHANISM OF JRNL TITL 2 ACTION OF HUMAN ANGIOGENIN-ALS VARIANTS IN NEURONS. JRNL REF NAT.COMMUN. V. 3 1121 2012 JRNL REFN ESSN 2041-1723 JRNL PMID 23047679 JRNL DOI 10.1038/NCOMMS2126 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.050 REMARK 3 COMPLETENESS FOR RANGE (%) : 80.4 REMARK 3 NUMBER OF REFLECTIONS : 3915 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 193 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.8817 - 2.7983 0.80 3722 193 0.2131 0.2783 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 47.60 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.17860 REMARK 3 B22 (A**2) : 19.48490 REMARK 3 B33 (A**2) : -9.30620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 974 REMARK 3 ANGLE : 1.279 1310 REMARK 3 CHIRALITY : 0.078 136 REMARK 3 PLANARITY : 0.006 174 REMARK 3 DIHEDRAL : 16.842 369 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4AHI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1290051151. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX10.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.045 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH SX-165 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4870 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.8 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 39.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1ANG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 REMARK 280 M NACL, 0.1 M HEPES PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.78200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 18.78200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.60200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.33300 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 41.60200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.33300 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 18.78200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.60200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.33300 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 18.78200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 41.60200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.33300 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2003 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 64 TO ILE REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1 REMARK 465 ASP A 2 REMARK 465 ASN A 3 REMARK 465 ARG A 122 REMARK 465 PRO A 123 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 16 -74.25 -38.71 REMARK 500 GLN A 19 -72.19 -121.25 REMARK 500 ARG A 21 65.86 -104.70 REMARK 500 LEU A 35 50.28 -108.60 REMARK 500 ASN A 59 -1.68 -57.64 REMARK 500 HIS A 65 116.27 -162.83 REMARK 500 ARG A 66 -146.10 62.16 REMARK 500 PRO A 90 153.83 -48.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HBY RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1H53 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 2ANG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM REMARK 900 RELATED ID: 1UN3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D REMARK 900 RELATED ID: 1A4Y RELATED DB: PDB REMARK 900 RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX REMARK 900 RELATED ID: 1B1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. REMARK 900 RELATED ID: 1UN4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A REMARK 900 RELATED ID: 1UN5 RELATED DB: PDB REMARK 900 ARH-II, AN ANGIOGENIN/RNASE A CHIMERA REMARK 900 RELATED ID: 1H0D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT REMARK 900 OF ITS MONOCLONAL ANTIBODY MAB 26-2F REMARK 900 RELATED ID: 1K59 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT Q117G REMARK 900 RELATED ID: 1B1E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q REMARK 900 RELATED ID: 1K5B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT DES(121- 123) REMARK 900 RELATED ID: 1K58 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT D116H REMARK 900 RELATED ID: 1ANG RELATED DB: PDB REMARK 900 ANGIOGENIN REMARK 900 RELATED ID: 1K5A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN DOUBLE VARIANTI119A /F120A REMARK 900 RELATED ID: 1AWZ RELATED DB: PDB REMARK 900 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR REMARK 900 SPECTROSCOPY, 30 STRUCTURES REMARK 900 RELATED ID: 1B1I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REMARK 900 RELATED ID: 1H52 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 4AHF RELATED DB: PDB REMARK 900 K17E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHE RELATED DB: PDB REMARK 900 K17I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHD RELATED DB: PDB REMARK 900 Q12L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHH RELATED DB: PDB REMARK 900 R31K - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHJ RELATED DB: PDB REMARK 900 I46V - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHK RELATED DB: PDB REMARK 900 K54E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHL RELATED DB: PDB REMARK 900 P112L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHM RELATED DB: PDB REMARK 900 V113I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHG RELATED DB: PDB REMARK 900 S28N - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS DBREF 4AHI A 1 123 UNP P03950 ANGI_HUMAN 25 147 SEQADV 4AHI ILE A 40 UNP P03950 LYS 64 ENGINEERED MUTATION SEQRES 1 A 123 GLN ASP ASN SER ARG TYR THR HIS PHE LEU THR GLN HIS SEQRES 2 A 123 TYR ASP ALA LYS PRO GLN GLY ARG ASP ASP ARG TYR CYS SEQRES 3 A 123 GLU SER ILE MET ARG ARG ARG GLY LEU THR SER PRO CYS SEQRES 4 A 123 ILE ASP ILE ASN THR PHE ILE HIS GLY ASN LYS ARG SER SEQRES 5 A 123 ILE LYS ALA ILE CYS GLU ASN LYS ASN GLY ASN PRO HIS SEQRES 6 A 123 ARG GLU ASN LEU ARG ILE SER LYS SER SER PHE GLN VAL SEQRES 7 A 123 THR THR CYS LYS LEU HIS GLY GLY SER PRO TRP PRO PRO SEQRES 8 A 123 CYS GLN TYR ARG ALA THR ALA GLY PHE ARG ASN VAL VAL SEQRES 9 A 123 VAL ALA CYS GLU ASN GLY LEU PRO VAL HIS LEU ASP GLN SEQRES 10 A 123 SER ILE PHE ARG ARG PRO FORMUL 2 HOH *10(H2 O) HELIX 1 1 SER A 4 TYR A 14 1 11 HELIX 2 2 ASP A 22 ARG A 33 1 12 HELIX 3 3 ASN A 49 ALA A 55 1 7 HELIX 4 4 ILE A 56 GLU A 58 5 3 HELIX 5 5 GLN A 117 ARG A 121 5 5 SHEET 1 AA 3 ILE A 42 ILE A 46 0 SHEET 2 AA 3 PHE A 76 HIS A 84 -1 O THR A 79 N PHE A 45 SHEET 3 AA 3 GLN A 93 ARG A 101 -1 O GLN A 93 N HIS A 84 SHEET 1 AB 4 ASN A 63 HIS A 65 0 SHEET 2 AB 4 LEU A 69 ILE A 71 -1 O LEU A 69 N HIS A 65 SHEET 3 AB 4 VAL A 104 GLU A 108 -1 O VAL A 105 N ARG A 70 SHEET 4 AB 4 LEU A 111 LEU A 115 -1 O LEU A 111 N GLU A 108 SSBOND 1 CYS A 26 CYS A 81 1555 1555 2.04 SSBOND 2 CYS A 39 CYS A 92 1555 1555 1.99 SSBOND 3 CYS A 57 CYS A 107 1555 1555 2.03 CISPEP 1 SER A 37 PRO A 38 0 -1.30 CISPEP 2 PRO A 90 PRO A 91 0 -1.49 CRYST1 83.204 118.666 37.564 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012019 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008427 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026621 0.00000